TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12592272

Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg every 6 hours for two doses
Number of subjects: 111

Group type: COMPARATOR
Intervention: Dinoprostone insert 10 mg for one dose intravaginally
Number of subjects: 111

Group type: COMPARATOR
Intervention: Dinoprostone gel 0.5 mg every 6 hours for two doses
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 111

Group type: COMPARATOR
Intervention: Dinoprostone gel
Number of subjects: 111

Group type: COMPARATOR
Intervention: Dinoprostone insert
Number of subjects: 111
Study: 10495374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Finasteride 0.01 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Finasteride 0.05 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Finasteride 0.2 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 249
Study: 8792367

Group type: EXPERIMENTAL
Intervention: Pneumatic tourniquet use during arthroscopic meniscectomy
Number of subjects: 34

Group type: COMPARATOR
Intervention: No tourniquet use during arthroscopic meniscectomy
Number of subjects: 34
Study: 1716916

Group type: EXPERIMENTAL
Intervention: 6 percent carboxyhemoglobin
Number of subjects: 41

Group type: COMPARATOR
Intervention: room air
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 4 percent carboxyhemoglobin
Number of subjects: 41
Study: 7062377

Group type: EXPERIMENTAL
Intervention: Povidone-iodine irrigation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 80
Study: 31065046

Group type: EXPERIMENTAL
Intervention: High concentrations of valine, leucine, isoleucine, phenylalanine, tyrosine, alanine, glutamate, ornithine, and lysine
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: High glutamine concentrations
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Adjustment for homeostasis model assessment of insulin resistance
Number of subjects: 284
Study: 28811733

Group type: EXPERIMENTAL
Intervention: Community engagement and planning (CEP)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 423
Study: 25582097

Group type: EXPERIMENTAL
Intervention: Mobile application counseling
Number of subjects: 120

Group type: COMPARATOR
Intervention: Health educator counseling
Number of subjects: 120
Study: 23860105

Group type: EXPERIMENTAL
Intervention: Padma Digestin (2 × 3 capsules daily for 6 weeks)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Padma Digestin
Number of subjects: 37
Study: 21865569

Group type: EXPERIMENTAL
Intervention: 2 servings of vegetables (130 g)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 5 servings of vegetables (287 g)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 10 servings of vegetables (614 g)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All doses of vegetables
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control for oxidative stress and inflammation
Number of subjects: 49
Study: 19967149

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day (n = 28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no statins, n = 28)
Number of subjects: 56
Study: 17720325

Group type: COMPARATOR
Intervention: BI (1 session)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: BIB (2 sessions)
Number of subjects: 249
Study: 14997965

Group type: EXPERIMENTAL
Intervention: Segmented air cushion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Contoured viscous fluid/foam cushion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Air/foam cushion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Backrest height referenced to T12
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Backrest height referenced to inferior scapular angle
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Backrest height referenced to scapular spine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Increased posterior pelvic tilt
Number of subjects: 22
Study: 11113085

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg orally 3 times daily
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 101
Study: 9194783

Group type: EXPERIMENTAL
Intervention: Local anesthetic infiltration of the wound before incision
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline infiltration
Number of subjects: 43
Study: 1549966

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 90 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 180 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 360 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem CD 540 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2421976

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dextran 70 (0.5 L)
Number of subjects: 31
Study: 31603996

Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 2000
Study: 28744931

Group type: EXPERIMENTAL
Intervention: Nutrition workshop (50 minutes)
Number of subjects: 3291

Group type: COMPARATOR
Intervention: Promotion of unhealthy beverages
Number of subjects: 3291
Study: 24758073

Group type: EXPERIMENTAL
Intervention: Etanercept plus Tripterygium wilfordii polyglycoside (TWP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 46
Study: 22659533

Group type: EXPERIMENTAL
Intervention: Add-on ezetimibe (10 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Double-dose pravastatin
Number of subjects: 100
Study: 20129634

Group type: EXPERIMENTAL
Intervention: Doxycycline-chloroquine
Number of subjects: 936

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 936
Study: 18589030

Group type: EXPERIMENTAL
Intervention: Algal-oil capsules (600 mg DHA/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cooked salmon (assayed portions)
Number of subjects: 32
Study: 15964928

Group type: EXPERIMENTAL
Intervention: Tetrahydrobiopterin (BH(4), 500 microg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vitamin C (24 mg/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 8

Group type: COMPARATOR
Intervention: LPS
Number of subjects: 8
Study: 11796586

Group type: EXPERIMENTAL
Intervention: Monovalent meningococcal B OMV vaccine
Number of subjects: 134
Study: 10320158

Group type: EXPERIMENTAL
Intervention: Intravenous lactated Ringer's solution (LR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (NS)
Number of subjects: 18
Study: 8916607

Group type: EXPERIMENTAL
Intervention: Increase fluid intake by 500 cc
Number of subjects: 32

Group type: COMPARATOR
Intervention: Maintain fluid intake at baseline level
Number of subjects: 32

Group type: COMPARATOR
Intervention: Decrease fluid intake by 300 cc
Number of subjects: 32
Study: 1790544

Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg daily for 60 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6125089

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.75 mg to 3 mg per day, average final dose: 1.59 mg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Lorazepam (3 mg to 12 mg per day, average final dose: 5.97 mg)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 74

Group type: COMPARATOR
Intervention: Lorazepam
Number of subjects: 74
Study: 31665879

Group type: EXPERIMENTAL
Intervention: Tai Chi training plus routine exercise
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine exercise
Number of subjects: 41
Study: 31095627

Group type: EXPERIMENTAL
Intervention: Modified CAD/CAM generated intermediate wafer
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional CAD/CAM generated intermediate wafer
Number of subjects: 20
Study: 28379800

Group type: EXPERIMENTAL
Intervention: Body-weight variability (measured according to average successive variability)
Number of subjects: 9509

Group type: EXPERIMENTAL
Intervention: Body-weight variability (highest quintile)
Number of subjects: 9509
Study: 26513005

Group type: EXPERIMENTAL
Intervention: Chocolate Milk (CM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 12
Study: 24953582

Group type: EXPERIMENTAL
Intervention: Community and school-based events incorporating an animated film, skits, and public pledging ceremonies
Number of subjects: 14

Group type: COMPARATOR
Intervention: Shortened intervention (after control villages received it)
Number of subjects: 14
Study: 22237883

Group type: EXPERIMENTAL
Intervention: Lipid emulsion containing medium-chain triglycerides (MCTs), soybean, olive, and fish oils
Number of subjects: 53

Group type: COMPARATOR
Intervention: Soybean oil emulsion
Number of subjects: 53
Study: 19345873

Group type: EXPERIMENTAL
Intervention: FiberWire
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ticron
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Prolene
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Repair of both FDP and FDS tendons
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Repair of FDP only
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Repair of one slip of FDS and resection of the other
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resection of 1 slip of FDS tendon
Number of subjects: 10
Study: 17727574

Group type: EXPERIMENTAL
Intervention: Desmopressin for PMNE associated with nocturnal polyuria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alarms for PMNE with reduced bladder capacity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies for refractory cases of NE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxybutinin for a small subgroup with overactive bladder during sleep
Number of subjects: 0
Study: 15246890

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study: 11432111

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 91

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 91
Study: 9699022

Group type: EXPERIMENTAL
Intervention: Selenium-enriched yeast supplementation (4.8 mg yeast containing 5 microgram selenium daily via naso-gastric drip for 14 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonsupplemented (control) group
Number of subjects: 28
Study: 7795013

Group type: EXPERIMENTAL
Intervention: Rehabilitation program developed by unit 304 of Louis H. Lafontaine Hospital
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control patients (paired by age, sex, and years of hospitalization)
Number of subjects: 0
Study: 2506874

Group type: EXPERIMENTAL
Intervention: Intralipid 20% administered to ten infants
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil rubbed six times daily on the skin of nine infants
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intralipid administered to four patients who had previously received sunflower seed oil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Topical application of sunflower seed oil
Number of subjects: 19
Study: 155294

Group type: EXPERIMENTAL
Intervention: ipratropin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 24
Study: 30094626

Group type: EXPERIMENTAL
Intervention: Commonly recommended dosing of omeprazole
Number of subjects: 64

Group type: COMPARATOR
Intervention: Suboptimal dosing of omeprazole
Number of subjects: 64
Study: 27663604

Group type: EXPERIMENTAL
Intervention: Covered TIPS (n = 29)
Number of subjects: 62

Group type: COMPARATOR
Intervention: LVP+A (n = 33)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 25968578

Group type: EXPERIMENTAL
Intervention: Hindlimb unloading (HU) in wild-type (WT) mice for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hindlimb unloading (HU) in MyD88(‐/‐) mice for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 days of bed rest in older adults
Number of subjects: 0
Study: 23987013

Group type: EXPERIMENTAL
Intervention: Autogenous bone pate for atticus reconstitution and mastoid cavity obliteration in canal wall down mastoidectomy with tympanoplasty
Number of subjects: 60

Group type: COMPARATOR
Intervention: Canal wall down mastoidectomy with tympanoplasty (control group)
Number of subjects: 60
Study: 21300730

Group type: EXPERIMENTAL
Intervention: AAIR pacing
Number of subjects: 1415

Group type: COMPARATOR
Intervention: DDDR pacing
Number of subjects: 1415
Study: 18472409

Group type: EXPERIMENTAL
Intervention: Dietary intervention (n=233)
Number of subjects: 563

Group type: COMPARATOR
Intervention: No dietary intervention (n=231)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 563
Study: 17413100

Group type: EXPERIMENTAL
Intervention: MUFA diet (n = 12)
Number of subjects: 27

Group type: COMPARATOR
Intervention: LF diet (n = 15)
Number of subjects: 27
Study: 16732144

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (2 mg/kg per day in three divided doses for 3 days)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 12600864

Group type: EXPERIMENTAL
Intervention: Mixed tocopherols
Number of subjects: 46

Group type: COMPARATOR
Intervention: Alpha‐tocopherol
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control
Number of subjects: 46
Study: 10343208

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 198

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 198
Study: 8955466

Group type: EXPERIMENTAL
Intervention: Skin-to-skin with father
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cot
Number of subjects: 44

Group type: COMPARATOR
Intervention: Incubator
Number of subjects: 44
Study: 1834443

Group type: EXPERIMENTAL
Intervention: Insufflatable abdominal girdle (IAG)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no IAG)
Number of subjects: 160
Study: 6179975

Group type: EXPERIMENTAL
Intervention: Double-blind food challenge (DBFC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Skin test
Number of subjects: 22

Group type: COMPARATOR
Intervention: Leukocyte histamine release (LHR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: RAST
Number of subjects: 22
Study: 31256328

Group type: EXPERIMENTAL
Intervention: Pink Pad®
Number of subjects: 60

Group type: COMPARATOR
Intervention: egg‐crate foam
Number of subjects: 60
Study: 30593173

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 53
Study: 27103222

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 18
Study: 24005332

Group type: EXPERIMENTAL
Intervention: EZLoc femoral fixation device
Number of subjects: 110

Group type: COMPARATOR
Intervention: Bone Mulch Screw
Number of subjects: 110
Study: 20720484

Group type: EXPERIMENTAL
Intervention: Heptaminol hydrochloride
Number of subjects: 49
Study: 20629576

Group type: EXPERIMENTAL
Intervention: Alternate vaccination schedule at 0, 2, and 12 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard vaccination schedule at 0, 2, and 6 months
Number of subjects: 200
Study: 18780503

Group type: EXPERIMENTAL
Intervention: Penehyclidine hydrochloride (0.01 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Atropine (0.01 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Scopolamine (0.006 mg/kg)
Number of subjects: 120
Study: 16038528

Group type: EXPERIMENTAL
Intervention: Midazolam + chemotherapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Propofol + chemotherapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (chemotherapy only)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Midazolam + chemotherapy and Propofol + chemotherapy
Number of subjects: 45
Study: 12518498

Group type: EXPERIMENTAL
Intervention: Triclosan/pyrophosphate dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triclosan placebo dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium fluoride control (NaF) dentifrice
Number of subjects: 0
Study: 10527293

Group type: EXPERIMENTAL
Intervention: Omeprazole test
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 7724308

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine
Number of subjects: 59

Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 59
Study: 1823965

Group type: COMPARATOR
Intervention: Induction therapy based on melphalan
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Polychemotherapy including vincristine, melphalan, carmustine, cyclophosphamide and prednisone
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Chemotherapy supported by immunomodulatory agents (calf thymus extract, levamisole, interferon)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Calf thymus extract
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 208
Study: 7036438

Group type: EXPERIMENTAL
Intervention: Chloroquine (25 mg/kg over three days)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Fansidar (35 mg sulphadoxin (+ 1/20 pyrimethamine) per kg single dose)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Chloroquine and Fansidar
Number of subjects: 58
Study: 30982782

Group type: EXPERIMENTAL
Intervention: Acupressure applied to acupuncture points (PC‐6, HT‐7, CV‐17), twice per day (2-4 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (no pressure applied)
Number of subjects: 60
Study: 26799154

Group type: EXPERIMENTAL
Intervention: Implant-assisted mandibular removable partial dentures
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stage 1 (healing caps)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stage 2 (attachment system)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (conventional mandibular partial dentures)
Number of subjects: 48
Study: 25760153

Group type: EXPERIMENTAL
Intervention: Traditional Periodization (TP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 10
Study: 23390192

Group type: EXPERIMENTAL
Intervention: EPA (1000 mg EPA:200 mg DHA)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: DHA (200 mg EPA:1000 mg DHA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: EPA
Number of subjects: 94

Group type: COMPARATOR
Intervention: DHA
Number of subjects: 94
Study: 22353416

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide + Ankaferd Blood Stopper (CH+ABS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Calcium Hydroxide (CH)
Number of subjects: 40
Study: 19379993

Group type: EXPERIMENTAL
Intervention: Miniaturized extracorporeal circulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 60
Study: 16924018

Group type: EXPERIMENTAL
Intervention: 14‐3‐3 protein
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Tau protein
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Combined determination of 14‐3‐3 and Tau, S100b, or NSE
Number of subjects: 1859

Group type: EXPERIMENTAL
Intervention: Second lumbar puncture
Number of subjects: 1859
Study: 12716332

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (PTB) with brushing force of 75 g for 30, 60, 120, and 180 seconds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (PTB) with brushing force of 150 g for 30, 60, 120, and 180 seconds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (PTB) with brushing force of 225 g for 30, 60, 120, and 180 seconds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Powered toothbrush (PTB) with brushing force of 300 g for 30, 60, 120, and 180 seconds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Brushing time of 120 seconds with forces in excess of 150 g
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Brushing time of 30, 60, 120, and 180 seconds with varying forces
Number of subjects: 12
Study: 10938215

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (used for the first 35 days)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (removed after 35 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (nonsmokers)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (for females)
Number of subjects: 27
Study: 8828742

Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (1 patient)
Number of subjects: 10
Study: 1345900

Group type: EXPERIMENTAL
Intervention: Broxaterol (0.5 mg three times a day for seven days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6369694

Group type: EXPERIMENTAL
Intervention: DTIC alone
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DTIC + bacillus Calmette‐Guérin
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DTIC + Corynebacterium parvum
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Responders
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Patients with brain metastases
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Toxic effects
Number of subjects: 196
Study: 29368539

Group type: EXPERIMENTAL
Intervention: ADS-5102 (amantadine) 274 mg once daily at bedtime
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28100469

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 2471

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2471
Study: 25962889

Group type: EXPERIMENTAL
Intervention: Supervised, facility-based exercise arm
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Home-based exercise arm
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (maintains physical activity levels)
Number of subjects: 240